AEterna Zentaris (T.AEZ) shares hit a 52 week high of $1.58. The company announced today that it will present two posters on its PI3K inhibitor compound, AEZS-126, as well as a poster on its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, at the American Association for Cancer Research Annual Meeting, to be held on April 18-22, 2009 at the Colorado Convention Center in Denver, Colorado.
Paladin Labs (T.PLB) shares touched a fresh 52 week high of $14.90. No major news today.
